Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma.

[1]  C. Kwak,et al.  Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.

[2]  T. Powles,et al.  Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). , 2021 .

[3]  C. Beisland,et al.  Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study , 2021, World Journal of Urology.

[4]  A. Masson-Lecomte,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. , 2020, European urology.

[5]  Kun-lin Yang,et al.  Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma , 2020, World Journal of Surgical Oncology.

[6]  J. Donovan,et al.  Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial , 2020, The Lancet.

[7]  Simon P. Kim,et al.  Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management , 2019, World Journal of Urology.

[8]  Young Seok Kim,et al.  Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study. , 2019, International journal of radiation oncology, biology, physics.

[9]  M. Babjuk,et al.  Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer. , 2017, European urology focus.

[10]  D. Matsuda,et al.  Investigation of estimated glomerular filtration rate and its perioperative change in patients with upper urinary tract urothelial carcinoma: A multi‐institutional retrospective study , 2018, Asia-Pacific journal of clinical oncology.

[11]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.

[12]  Steven L. Chang,et al.  Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Ying-Hsu Chang,et al.  Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma , 2016, Scientific Reports.

[14]  V. Bhatt,et al.  Effect of Adjuvant Radiotherapy on Survival in Patients with Locoregional Urothelial Malignancies of the Upper Urinary Tract. , 2016, Anticancer research.

[15]  A. Horváth,et al.  Why are upper tract urothelial carcinoma two different diseases? , 2016, Translational andrology and urology.

[16]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[17]  Chien-Feng Li,et al.  The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma , 2016, Annals of Surgical Oncology.

[18]  K. Bensalah,et al.  Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis , 2014, BJU international.

[19]  Xuesong Li,et al.  Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy , 2014, BioMed research international.

[20]  Young Seok Kim,et al.  Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract. , 2014, Anticancer research.

[21]  P. Black,et al.  Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. , 2014, Urologic oncology.

[22]  M. Jinzaki,et al.  Metastatic Behavior of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Association with Primary Tumor Location , 2014, Annals of Surgical Oncology.

[23]  K. Moon,et al.  External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2013, British Journal of Cancer.

[24]  A. Ouzzane,et al.  Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy , 2013, BJU international.

[25]  K. Bensalah,et al.  Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. , 2013, The Journal of urology.

[26]  F. Zhou,et al.  Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy , 2013, International Urology and Nephrology.

[27]  J. Catto,et al.  Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours , 2013, World Journal of Urology.

[28]  David A. Green,et al.  Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. , 2012, European urology.

[29]  K. Bensalah,et al.  Risk of Cancer-specific Mortality following Recurrence After Radical Nephroureterectomy , 2012, Annals of Surgical Oncology.

[30]  K. Bensalah,et al.  Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. , 2012, European urology.

[31]  S. Crouzet,et al.  Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram , 2012, British Journal of Cancer.

[32]  K. Bensalah,et al.  The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. , 2012, European urology.

[33]  M. Dimopoulos,et al.  Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) , 2011, Cancer.

[34]  S. Shariat,et al.  No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study , 2011, World Journal of Urology.

[35]  Yuan Ji,et al.  Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse , 2011, BMC Cancer.

[36]  M. Stifelman,et al.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.

[37]  A. Finelli,et al.  Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. , 2009, Urology.

[38]  A. Ouzzane,et al.  Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract , 2009, BJU international.

[39]  K. Bensalah,et al.  Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. , 2009, The Journal of urology.

[40]  Y. Lotan,et al.  Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.

[41]  R. Hautmann,et al.  Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. , 2005, The Journal of urology.

[42]  F. Burkhard,et al.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  L. Ellison,et al.  Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. , 2000, The Journal of urology.

[45]  M. Housset,et al.  Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? , 1996, The Journal of urology.

[46]  S. Smalley,et al.  Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. , 1995, Urology.